Results 51 to 60 of about 6,061 (168)
Supplemental material, sj-docx-1-ejo-10.1177_11206721211056585 for Safety, efficacy, and timing of Nd:YAG laser goniopuncture after nonpenetrating deep sclerectomy for glaucoma: A retrospective cohort study by Grant Slagle, Tyler Bahr, Kyle Welburn ...
Tyler Bahr (11713039) +5 more
core +1 more source
The aim of our paper was to make a series of experiments in order to determine the concentration at which four cryoprotectants (DMSO, sucrose, Ficoll 70 and galactose) singly and in pairs would vitrify on plunging into liquid nitrogen and remain vitreous
ADA TELEA +4 more
doaj
Aim. To compare the hypotensive effect of non-penetrating deep sclerectomy (NPDS) as a standalone surgery and non-penetrating deep sclerectomy in combination with dosed endotrabeculectomy in patients with primary open-angle glaucoma.
Olha Levytska, Ihor Novytskyi
doaj +1 more source
This paper investigates the high‐pressure water jet‐pick combined rock‐breaking mode (HPC), which employs high‐pressure water jets to precut grooves on both sides of the picks. The rock‐breaking patterns and performance of the HPC method are obtained, and the auxiliary rock‐breaking mechanism of water jet grooving is revealed.
Jingjing Lu +6 more
wiley +1 more source
BACKGROUND: Neodymium-doped yttrium aluminum garnet laser goniopuncture is an adjuvant procedure for nonpenetrating deep sclerectomy. We investigated optimal laser goniopuncture timing and the effect of laser iridoplasty on success rates.
Quittner-Strom, Ezekiel +5 more
core +1 more source
Combination of Upadacitinib and Risankizumab in Refractory Crohn's Disease
ABSTRACT Background and Aim Dual targeted therapies (DTT) are a promising off‐label approach for the treatment of refractory Crohn's disease (CD). Upadacitinib and risankizumab are approved for the treatment of moderate to severe CD. Our aim was to evaluate the effectiveness and safety of a combination of upadacitinib and risankizumab for refractory CD.
Clara Ramos‐Belinchon +5 more
wiley +1 more source
A Distinct Tryptophan Metabolic Phenotype Marks Severe Fatigue in Quiescent Crohn's Disease
ABSTRACT Background Fatigue is a common and debilitating symptom in inflammatory bowel disease (IBD), but its underlying mechanisms remain unclear. Altered tryptophan metabolism may contribute to fatigue. Tryptophan is metabolized through the kynurenine, serotonin, and indole pathway, involving host and microbial processes. We aimed to explore the link
Paula I. Metselaar +12 more
wiley +1 more source
A novel diagnostic serum protein signature for pediatric inflammatory bowel disease
Abstract Objectives Diagnostic delay is common in pediatric inflammatory bowel disease (PIBD), and fecal calprotectin (FCP) is often limited by challenges with sample collection. Therefore, we aimed to identify and validate a blood‐based diagnostic protein signature of PIBD.
Charlotte Bache‐Wiig Mathisen +22 more
wiley +1 more source
Real‐world data on STRIDE‐II treatment targets in a pediatric cohort with inflammatory bowel disease
Abstract Objectives STRIDE (selecting therapeutic targets in inflammatory bowel disease) established evidence‐based targets for treat‐to‐target strategies in inflammatory bowel disease (IBD). STRIDE‐II designates clinical remission, C‐reactive protein (CRP) normalization, and fecal calprotectin (FC) reduction as short‐ to intermediate‐term targets, and
Marie‐Luise Frank +9 more
wiley +1 more source
PURPOSE: Iris incarceration is a complication of glaucoma filtering surgery that often requires surgery. We describe a technique for reduction of incarcerated iris at the slit lamp, dubbed rotational extraction of incarcerated iris (REII).
Griffin, Jeffrey +2 more
core +1 more source

